Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do you own POSC?........I believe it is time to separate the traders looking for a quick profit and investors that have done their own due diligence. What has changed? IMO not much. BMR got this story way ahead of itself by mentioning COV by name. POSC hands were tied at the May 5 conference and the CEO gave an explanation for that. Both parties were exploring the possibility of expanding the relationship and mutually decided that releasing the name would give away certain competitive advantages. So it might take a little longer than ANYONE expected. If you believe in management and believe news is coming, not only on COV, but many other large deals with huge companies, than this is short term down movement in the stock is tough to stomach but doesn't matter in the long run. Ask yourself this....why did you buy the stock in the first place? There has been no bad news. Its the same company.
Look at the products the have and the position that they have put themselves in. Most news coming out at the SNM conference is about PET. Reimbursement is moving to PET. I am telling everyone I know...BUY MORE at these prices but at the very least...take a deep breathe, hold your position and be patient.Easier said than done .....but I am believer.
If you are looking for a reason to sell...maybe you should just go ahead and sell because there are a million reasons to sell, but only 1 reason to hold. Because the stock trades higher . I am totally convinced that trades significantly higher before the end of June !!!!!!!!!!
wasn't me
roelien do you have an email i can send you something?
why dont you post it?
i think we will get some good news this week and great news by the end of june
imo
yes some of those promotional websites jump on the band wagon after the fact and claim it as 1 of their winners.
attn roelien.....the info you sent me was from 2007 and i don't think it is current enough to warrant a sticky.
it shows it was deleted because it was a personal attack. however i did not remove it.
so why don't you sell and move on to something else?
We are currently experiencing technical difficulties with Ustream. Please call in to listen to the press conference: Telephone:* (877) 511-9945 (from the U.S. and Canada); 706-679-8470 (international callers) *All callers should use Conference ID: 79399968
8-K for IMAGIN MOLECULAR CORP
--------------------------------------------------------------------------------
4-Jun-2010
Change in Directors or Principal Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Agreements of Certain Officers.
On June 3, 2010, Joseph G. Oliverio resigned as Director and Chief Executive Officer of the Registrant, Corey Conn resigned as Director and Chief Financial Officer of the Registrant and Neil Sy resigned as Director of the Registrant.
On June 3, 2010, Patrick J. Rooney, Ghassan Barazi and Nicholas Anthony Havercroft were elected and appointed to the Board of Directors of the Registrant. Also on that date, Mr. Rooney was appointed Director of Corporate Development and Mr. Barazi was appointed the Registrant's President.
Patrick J. Rooney, 70, Chairman and Director of Corporate Development. Mr. Rooney is a co-founder of the Planet Green Bottle Corporation and has served as its Director of Corporate Development since 2008. Simultaneously therewith and since 2004, Mr. Rooney has served as Director of Corporation Development for IMAGIN Diagnostic Centres, Inc. ("IDC") a Canadian company which is a pioneer in imaging-based cancer, cardiac and neurological disease diagnosis. Mr. Rooney became CEO and sole director of IDC in February, 2007. Patrick Rooney has a long career of founding and funding early stage technology-based medical and environmental companies that have a purpose of making a contribution to the health and well-being of society. Historically Mr. Rooney has completed approximately 150 initial public offering (IPO's) and/or reverse mergers. Mr. Rooney was the control shareholder and CEO of an office services company Services Resources Corporation (name changed to Ameriscribe) whose shares were listed on the N.Y.S.E. and was sold to Pitney Bowes.
On September 27, 2007 the Ontario Securities Commission alleged that Mr. Rooney and IDC traded in securities of IDC without registration. Mr. Rooney and IDC have opposed the allegation. After a hearing, a decision has not yet been rendered by the OSC. In 1987, Mr. Rooney was charged by the United States with tax evasion and signing a false tax return for taxes due for the taxable year 1983. At trial Mr. Rooney was acquitted of tax evasion and convicted of signing a false tax return. The amount of tax unpaid as calculated on his 1983 tax return charged in the offence was $9,000. Mr. Rooney paid taxes in excess of $800,000 in 1983 and it was demonstrated at trial that Mr. Rooney in fact overpaid his 1983 taxes therefore an acquittal for tax evasion resulted. In 2001, Mr. Rooney settled a civil case with the Securities and Exchange Commission on alleged insider trading, without denying or admitting wrongdoing and agreed not to conduct activities paramount to operating as a broker/dealer. Mr. Rooney agreed to a settlement which included return of profits and penalties in an amount of $1,800,000.
Ghassan Barazi, 46, President, Director. Since 2007, Mr. Barazi has served as the CEO of CARE Imaging Centres, and CI Pharma, both companies involved in performing PET (positron emission tomography) scans for cancer patients. Mr. Barazi, a mechanical engineer, started his career when he formed Cad Venture, a company specializing in computer aided design for the mold, and tool and die industry related to the automotive manufacturers. He redirected his career to the medical business as a co-founder of The Windsor Laser Eye Institute. Barazi helped launched ICON Laser Eye Centers Inc. in Canada in 1995. ICON became the fastest growing Lasik Company in the world, boasting more than 40 centers in Europe, Canada, and the USA. Mr. Barazi established a marketing concept around "The War Room" a centralized call center, backed by a web-based driven patient acquisition methodology and value pricing. Mr. Barazi is considered a marketing expert especially in the segment defined as the retail medicine industry.
Nicholas Anthony Havercroft, 45, Director. Mr. Havercroft is a co-founder of the Planet Green Bottle Corporation and has served as its Chairman since 2008. Mr. Havercroft has successfully established and currently operates various large scale farming enterprises, steel manufacturing business, fruit and vegetable importing and tobacco manufacturing businesses.
sorry about the double post
someone told me that this board waas active...anyone here?
someone told me that this board waas active...anyone here?
i had no idea imgm board was active. i never even checked it out because the stock does not trade any volume.
i am sure they are busy with partnership due dilligence and the trade show but if i said it once i have said it dozens of times.......NO NEWS IS BAD NEWS IN PENNY STOCKS
as a bulletin board or pinksheet stock ESPECIALLY. you are competing for investment dollars with tousands of other companies. you must remain relevant in the minds of investors and potential investors with CONSISTENT news. it shows progress, pushes greed buttons and lets the investment community feel like they are being paid attention to.
POSC could be trading near .20 if they would just put out 1 or 2 releases a week even if it was small news.
WHOMP THERE IT IS..........In addition, the company distributes products through 3rd party distribution agreements and company owned radio pharmacies (principally located outside of theUS).
POSC and Lantheus connection.....from the POSC 8K filed after the may 5 conference
Our market research shows that there are 3,000 cardiology groups with this opportunity in addition to 4,000 hospitals. So we have quite a significant opportunity to capture this market share, being the only dedicated cardiac PET scanner.
We intend to rapidly expand our sales and marketing efforts to be able to furnish this supply to this increased demand. There are other companies also that will help push this demand. Lantheus Corporation currently is developing a cardiac PET drug. They're in Phase II clinical trials at the FDA. Information can be found at clinicaltrial.gov under the key word Lantheus.
They have a case study to fall back on. They developed the SPECT radiopharmaceutical that I initially spoke about in 1982. Procedural volumes of SPECT back then were 1,000 to 2,000 and John can also speak to that as a radiopharmacist.
Lantheus took SPECT imaging from 1,000 to 2,000 to 7 million procedures done currently per year. They have divested their interest from SPECT and are investing in cardiac PET specifically, a cardiac PET drug that performs well on our scanner. So we expect not only Positron as a driving force but Lantheus as well. This multi-billion dollar corporation pushing cardiac PET and that will certainly only benefit Positron Corporation.
I just spoke to Amy at SNM in the press release dept. the conference today will be for the following.
1st half for the top 5 researchers in the field doing presentations
2nd half for public policy and who can recieve certain types of treatment, info on medicare and medicade and the Moly shortage.
i read the info i was asking for the link or where he got that info from.
the source.
what news conference? where is the link?
Here is the full press release on Lantheus. PLEASE NOTE that it was released as news from POSC as well.
http://www.lantheus.com/News-Press-2010-0607.html
News out on Lantheus. I belive that when they complete their clinical test and get FDA approval, the Pharm-Asssist may be a distribution solution. Hence, why POSC mentioned that company during the MAy 5 conference, and why it was released as news for POSC.
http://www.lantheus.com/News-Press-2010-0607.html
i looked at the ontario site and saw an issue that included his father, but what does that have to do with POSC. don't you think cov or ge or anyone worth mentioning will have used their resocurces to do thier own due dilligence.
maybe ge as a financial partner and cov for pharm assist jv or something like that
i have not found anything good or bad about csti. i have not found any ties to big banks. i am not even sure it is relevant. just something i noticed on the level 2 over the last few weeks
Today is a perfect example of what I have said in previous posts.
People complain when the Dow is up 200 points and POSC is flat or down a bit. Well well the DOW is down over 300 points today and we are up slighlty.
My point is that they are really not related.
let me correct myself. i was the moderator on here about a year and a half ago and actually created the POSC profile that still exists. i am not sure how far you can go back but if you do you will see i was on here posting when the stock was .03 with no volume and not many people following or posting.
and just to clarify..i am not the moderator on this board. it is wareagle. who i do not know nad have never spoken to on or off of this board
i admit i have let emotions get the better of me and regret some over reactions but he said i would ban some one which is simply not true.
this is what he wrote
"Look Rick, I can see that if the credibility of POSC is brought into question it upsets you beyond what you can handle, and since you sound like the type of person to ban someone who doesn't agree with you, I won't post on this board anymore."
i am simply asking him about HIS motivation.
Mine is that I own a ton of stock. Why wouldn't I be emotional about money and those who lie in order to make it worth less.
If you were sellling your house and every time a potential buyer came to look at it a neighbor went up to them and told them you had mold in your attic....don't you think you would get a little pissed if it was a lie? well that is when i tend to lose it a bit.
i would have a little more respect for him if he were actually short POSC.
but he does not even have skin in the game
read his response then be the judge. my bet is when actually confronted, he does not even respond because there is no really rational answer. why does he waste his time? a strange hobby?
from your mouth to God's ears
i have never banned anyone from this board. i dont even think i could if i wanted to and i dont know how to
you are entitled to ur opinion and i am entitled to mine.
you seem to be the one who can't handle it.
i do have a serious question
if you no longer own the stock........why do you care? why do you take time out of your day to post questions or anything.
are you the kind of person who if he loses can not stand to see others win?
i really want to know.
i am sure a lot of people would love to know the answer to that.
it kind of reminds me of the guy at the horsetrack that loses all of his money but sticks around to tell everyone that will listen that it is all fixed and they have no shot at winning.
in a word....sad
i look forward to reading your response
if they do a deal with a NYSE major company and it has to do with the Pharnm Assist as most people think...then WHY WOULDDN'T they want to add sales people to promote their other products like the Attrrius PET sacnner?????????????????????????????????
sounds like a disgruntled ex shareholder comment. it never makes sense to me why someone who dosent own the stock takes time to post negative comments or try and through doubt into the conversation
sour grapes i guess
Has anyone else noticed that market maker CSTI has been very active latley in this stock and is often the insdie quote (highest bid and lowest offer)
Collins Stewart Inc. http://www.collins-stewart.com/index.asp
just a curious observation
Great Hire for POSC...Positron Announces the Addition of South Central Regional Sales Representative
.Companies:Positron Corporation.Press Release Source: Positron Corporation On Friday June 4, 2010, 12:24 pm
INDIANAPOLIS--(BUSINESS WIRE)--Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced today that Michael Stewart, BSRT, CNMT has joined Positron as its new South Central Regional Sales Representative. Mr. Stewart will be responsible for growing Positron’s sales of their AttriusTM cardiac optimized PET molecular imaging system throughout the region.
Mr. Stewart brings seventeen years of industry relationships and experience in the Nuclear Medicine arena; specifically in clinical diagnostic imaging, corporate accounts, medical devices and radiopharmaceutical sales. He holds a B.S. in Radiologic Technology with an emphasis in nuclear medicine from the University of Central Arkansas.
Positron Corporation's Chief Technology Officer, Mr. Joseph Oliverio, stated, "The addition of Michael Stewart to our team provides us with valuable experience from his clinical background in addition to his knowledge of pharmaceutical and medical device industry. We are confident he will help accelerate sales of the AttriusTM system in that region.”
Mr. Stewart stated, "I am excited about joining Positron, as I strongly believe they are ideally positioned within the nuclear cardiology market with the only dedicated PET currently offered. I look forward to helping them rapidly expand their install base."
About Positron: Positron founded in 1983, is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution. Positron products include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device; and the Tech-Assist™, a radiopharmaceutical injection shield. Positron is headquartered in Indianapolis, Indiana. More information about Positron is available at http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fus.lrd.yahoo.com%2F_ylt%3DAuoo_kFADPzRtg.wm9AERYbjba9_%3B_ylu%3DX3oDMTE2cTZmcXY3BHBvcwMxBHNlYwNuZXdzQXJ0Qm9keQRzbGsDd3d3cG9zaXRyb25j%2FSIG%3D167410c85%2F**http%253A%2Fcts.businesswire.com%2Fct%2FCT%253Fid%3Dsmartlink%2526url%3Dhttp%25253A%25252F%25252Fwww.positron.com%2526esheet%3D6080688%2526lan%3Den_US%2526anchor%3Dwww.positron.com%2526index%3D2%2526md5%3D0c6cec54a2a5c5a599b0af204e1af840&esheet=6316263&lan=en_US&anchor=www.positron.com&index=2&md5=cdeadb9bbc365f529e855cf703728b73.
Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.
For further information please contact Positron Corporation at (317)576-0183.
thanks for the info
i am ready to chew through the ropes myself! i want to have a good summer.
I think the stock would be much healthier with a consitent flow of news. COV has news just about every day.
ragingbull.com used to be really poplular but not so much anymmore